Affinity Asset Advisors, LLC Solid Biosciences Inc. Transaction History

Affinity Asset Advisors, LLC

  • $896 Million
  • Q1 2025

A detailed history of Affinity Asset Advisors, LLC transactions in Solid Biosciences Inc. stock. As of the latest transaction made, Affinity Asset Advisors, LLC holds 250,000 shares of SLDB stock, worth $1.15 Million. This represents 1.0% of its overall portfolio holdings.

Number of Shares
250,000
Holding current value
$1.15 Million
% of portfolio
1.0%

Shares

0 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
No transaction found.

Others Institutions Holding SLDB

# of Institutions
4
Shares Held
568
Call Options Held
0
Put Options Held
0
View Full List

About Solid Biosciences Inc.

SLDB Quotes by TradingView
  • Ticker SLDB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 7,533,080
  • Market Cap $34.7M
  • Description
  • Solid Biosciences Inc. engages in developing therapies for duchenne muscular dystrophy in the United States. The company's lead product candidate is SGT-001, a gene transfer candidate, which is in a Phase I/II clinical trial to drive functional dystrophin protein expression in patients' muscles; and SGT-003, a ext-generation gene transfer candid...
More about SLDB
Track This Portfolio

Track Affinity Asset Advisors, LLC Portfolio

Follow Affinity Asset Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Affinity Asset Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Affinity Asset Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email